• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The case of ivermectin: lessons and implications for improving access to care and treatment in developing countries.伊维菌素案例：对改善发展中国家医疗服务和治疗可及性的经验教训及启示
Community Eye Health. 2001;14(38):22-3.
2
Impact of ivermectin on illness and disability associated with onchocerciasis.伊维菌素对与盘尾丝虫病相关的疾病和残疾的影响。
Trop Med Int Health. 2004 Apr;9(4):A45-56. doi: 10.1111/j.1365-3156.2004.01213.x.
3
[Ivermectin. A new drug against onchocerciasis].[伊维菌素。一种治疗盘尾丝虫病的新药]
Tidsskr Nor Laegeforen. 1989 Jun 30;109(19-21):1999-2000.
4
Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis.美迪善捐赠计划20年控制盘尾丝虫病的操作经验教训。
Trop Med Int Health. 2008 May;13(5):689-96. doi: 10.1111/j.1365-3156.2008.02049.x.
5
Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.在罗阿丝虫感染流行地区用伊维菌素大规模治疗盘尾丝虫病后的严重反应。
Lancet. 1997 Jul 5;350(9070):18-22. doi: 10.1016/S0140-6736(96)11094-1.
6
[Ivermectin as a therapeutic alternative in neurocysticercosis that is resistant to conventional pharmacological treatment].[伊维菌素作为对传统药物治疗耐药的神经囊尾蚴病的一种治疗选择]
Rev Neurol. 2008;46(11):671-4.
7
Improving health services in developing countries with new types of public and allied health personnel.利用新型公共卫生及相关卫生人员改善发展中国家的卫生服务。
Ala J Med Sci. 1982 Oct;19(4):442-4.
8
Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS.在资源有限的环境中扩大丙型肝炎治疗的可及性：来自艾滋病的经验教训。
Clin Infect Dis. 2012 May;54(10):1465-72. doi: 10.1093/cid/cis227. Epub 2012 Mar 19.
9
Perinatal problems in developing countries: lessons learned and future challenges.
J Perinat Med. 2001;29(3):179-87. doi: 10.1515/JPM.2001.027.
10
Policy implications of health changes in rapidly developing countries: the case of Malaysia.快速发展国家健康变化的政策影响：以马来西亚为例。
J Public Health Policy. 1984 Dec;5(4):563-72.

引用本文的文献

1
Do Residents Believe that Onchocerciasis Transmission Was Eliminated? Results of A Post-Treatment Surveillance Knowledge, Attitude, and Practices Survey in Three Foci of Uganda.居民是否相信盘尾丝虫病传播已被消除？乌干达三个流行区治疗后监测知识、态度和实践调查的结果。
Am J Trop Med Hyg. 2024 Jun 25;111(3_Suppl):141-149. doi: 10.4269/ajtmh.23-0906. Print 2024 Sep 3.
2
Progress towards elimination of onchocerciasis in the Region du Sud-Ouest of Burkina Faso which was previously subject to a recrudescence event after vector control.布基纳法索西南大区在采取媒介控制措施后曾发生再猖獗事件，目前在消灭盘尾丝虫病方面取得了进展。
PLoS Negl Trop Dis. 2024 Apr 29;18(4):e0012118. doi: 10.1371/journal.pntd.0012118. eCollection 2024 Apr.
3
A positive consequence of the COVID-19 pandemic: how the counterfactual experience of school closures is accelerating a multisectoral response to the treatment of neglected tropical diseases.COVID-19 大流行带来的一个积极后果：学校关闭的反事实经验如何加速多部门对被忽视热带病治疗的应对。
Philos Trans R Soc Lond B Biol Sci. 2023 Oct 9;378(1887):20220282. doi: 10.1098/rstb.2022.0282. Epub 2023 Aug 21.
4
Importance of ivermectin to human onchocerciasis: past, present, and the future.伊维菌素对人类盘尾丝虫病的重要性：过去、现在与未来。
Res Rep Trop Med. 2011 May 30;2:81-92. doi: 10.2147/RRTM.S19477. eCollection 2011.
5
Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.确定撒哈拉以南非洲地区主要丝虫病的共同流行地区：在大规模药物治疗运动中寻求协同作用并预防严重不良事件。
Parasit Vectors. 2018 Jan 31;11(1):70. doi: 10.1186/s13071-018-2655-5.
6
Investing in Onchocerciasis Control: Financial Management of the African Programme for Onchocerciasis Control (APOC).盘尾丝虫病防治投资：非洲盘尾丝虫病防治计划（APOC）的财务管理
PLoS Negl Trop Dis. 2015 May 14;9(5):e0003508. doi: 10.1371/journal.pntd.0003508. eCollection 2015 May.
7
Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program.提高中低收入国家的医疗可及性：癌症药物获取项目中与入组和患者结局相关的制度因素。
BMC Health Serv Res. 2013 Aug 10;13:304. doi: 10.1186/1472-6963-13-304.
8
Interruption of Onchocerca volvulus transmission in the Abu Hamed focus, Sudan.在苏丹阿布哈迈德聚焦区阻断旋盘尾丝虫传播。
Am J Trop Med Hyg. 2013 Jul;89(1):51-7. doi: 10.4269/ajtmh.13-0112. Epub 2013 May 20.

The case of ivermectin: lessons and implications for improving access to care and treatment in developing countries.

作者信息

Sturchio J L

机构信息

Executive Director, Public Affairs Human Health - Europe, Middle East & Africa, Merck & Co., Inc, Box 100, Whitehouse Station, New Jersey 08889 - 0100, USA.

出版信息

Community Eye Health. 2001;14(38):22-3.

PMID:17491909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1705916/
Abstract
摘要